Leanne Kelly - 18 Sep 2025 Form 4 Insider Report for GRI Bio, Inc. (GRI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
22 Sep 2025, 16:06:10 UTC
Prior SEC filing
27 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Leanne Kelly

Key filing fact

Leanne Kelly filed Form 4 for GRI Bio, Inc. (GRI) on 22 Sep 2025.

Key facts

  • This page summarizes Leanne Kelly's Form 4 filing for GRI Bio, Inc. (GRI).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 22 Sep 2025, 16:06.

Change

  • Previous filing in this sequence was filed on 27 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001398278 Primary reporting owner

Kelly Leanne

Relationship
Chief Financial Officer
Address
C/O GRI BIO, INC., 2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA
Signature
/s/ Leanne Kelly
Signature date
22 Sep 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GRI transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+43,222
Change %
Price
$0.000000
Shares after
43,222
Date
18 Sep 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
43,222
Exercise price
$1.93
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Options to purchase 29,923 shares vested in full upon the date of grant and options to purchase 13,299 shares will vest in 12 substantially equal quarterly installments such that the stock option is fully vested on the third anniversary of the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .